AKT1 and breast carcinoma: Accordingly, to confirm the autophagy process occurring in the tested cells, we analyzed the level of Akt peptide in breast cancer cells (MCF-7 and MDA-MB-231) treated (treatment duration: 24 h) with the tested compounds (EDAG-1 and EDAG-8) and the conventionally used therapeutic agent (cisplatin) at 0.5 and 1 μM concentrations.